Weekly Bot Brief Newsletter on Robotics 7/9/2021
"There is no force on earth more powerful than an idea whose time has come." Victor Hugo
Bots in The News:
There was little to no gain in financial progress for either the broad market or the Bot Index. The S & P 500 increased 39 basis points while the bots gained a mere 7 basis points for the week. In reviewing the dispersion of performance, the components of the Bot Index had five stocks that gained more than 3% and five that declined greater than that target.
The winners were led by Yasakawa Electric that gained 6.13% on little news. Amazon was in second place in the performance derby, riding the coattails of new CEO Andy Jassy. The stock gained almost 6% as analysts are confident in the future of the succession plan.
The Swiss firm ABB Ltd. rose 4.23% after indicating it was considering a public listing spinoff of its e-mobility division. The division produces fast charging stations for electric vehicles and the IPO was anticipated to raise $3 billion in capital.
Apple increased 3.68% following Investor’s Business Daily’s headline article, “5 Dow Jones Stocks to Buy and Watch for July 2021: Apple Rallies.”
Of the weaker issues, the worst performer was the Chinese EV maker NIO Ltd. The company’s near 10% drop was a byproduct of the Chinese government’s reaction to DiDi’s IPO in the U.S. The crackdown on the Chinese ride share company took a nasty turn when the government’s cyberspace regulators began to impose tighter restrictions on data collection and data storage of international listed companies headquartered in China. Authorities have also instituted a more broadly pushing for companies to list domestically.
The remaining weaker names within the Bot Index included: shares of Oceaneering International (-5.31%), 3D Systems (-4.71%), Hiwin Technologies (-4.64%) and Tesla Inc. (-3.23%).
Making the Bite Less Painful:
Our friend Marian Tupy featured his Human Progress discussion this month on the little heralded creation of a vaccine to offset the effects of malaria. The transmission of disease by mosquitoes has purportedly killed 52 billion people over time and still accounts for the deaths of 400,000 annually. The new vaccine is designed to ‘kill any parasites that reached the liver or bloodstream, where they cause malaria symptoms. A success rate of 87.5% of the similar parasite has been noted.
While the death rate has been brought down to 400,000, the misery and malfunction of individuals and economic producers reaches 200 million per year. With strides in protecting, preventing, and curing malaria, the economic opportunities of many developing nations will allow their prosperity to flourish.
Member: American Economic Association, Society of Professional Journalists, United States Press Association. Institute of Chartered Financial Analysts, Robotic Industries Association, Member IEEE.
The Bot Brief is a weekly newsletter designed for economists, investment specialists, journalists, and academicians. It receives no remuneration from any companies that may from time to time be featured in the brief and its commentaries, analysis, opinions, and research represent the subjective views of Balcones Investment Research, LLC. Due to the complex and rapidly changing nature of the subject matter, the company makes no assurances as to the absolute accuracy of material presented.